These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11708662)

  • 1. Assessment of newly developed perfluorocarbon emulsion: oxygen carrying capacity as the blood substitute in vivo.
    Sakanoue J; Tamura M; Fukushima S; Takeuchi Y; Sakuma I; Kitabatake A
    Artif Cells Blood Substit Immobil Biotechnol; 2001 Sep; 29(5):389-97. PubMed ID: 11708662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfluorocarbons as blood substitutes.
    Waxman K
    Ann Emerg Med; 1986 Dec; 15(12):1423-4. PubMed ID: 3777615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluorocarbon-based red blood cell substitutes.
    Biro GP
    Transfus Med Rev; 1993 Apr; 7(2):84-95. PubMed ID: 8481603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes.
    Flaim SF
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1043-54. PubMed ID: 7849908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluorocarbon distribution to liver, lung and spleen of emulsions of perfluorotributylamine (FTBA) in pigs and rats and perfluorooctyl bromide (PFOB) in rats and dogs by 19F NMR spectroscopy.
    McGoron AJ; Pratt R; Zhang J; Shiferaw Y; Thomas S; Millard R
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1243-50. PubMed ID: 7849929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravascular behavior of a perfluorochemical emulsion.
    Tsuda Y; Yamanouchi K; Okamoto H; Yokoyama K; Heldebrant C
    J Pharmacobiodyn; 1990 Mar; 13(3):165-71. PubMed ID: 2374085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients.
    Suyama T; Yokoyama K; Naito R
    Prog Clin Biol Res; 1981; 55():609-28. PubMed ID: 7027272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent studies on perfluorochemical (PFC) emulsion as an oxygen carrier in Japan.
    Mitsuno T; Ohyanagi H; Yokoyama K; Suyama T
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):365-73. PubMed ID: 3052644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increases in brain tumor and cerebral blood flow by blood-perfluorochemical emulsion (Fluosol-DA) exchange.
    Hiraga S; Klubes P; Owens ES; Cysyk RL; Blasberg RG
    Cancer Res; 1987 Jun; 47(12):3296-302. PubMed ID: 3581070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a 3D volume 19F MR imaging protocol for mapping oxygen tension (pO2) in perfluorocarbons at low field.
    Pratt RG; Zheng J; Stewart BK; Shiferaw Y; McGoron AJ; Samaratunga RC; Thomas SR
    Magn Reson Med; 1997 Feb; 37(2):307-13. PubMed ID: 9001157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Half life and changes in the composition of a perfluorochemical emulsion within the vascular system of rats.
    Lutz J; Stark M
    Pflugers Arch; 1987 Sep; 410(1-2):181-4. PubMed ID: 3684504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling of oxygen transport in blood-perfluorocarbon emulsion mixtures: Part I: oxygen uptake in tubular vessels.
    Patel S; Mehra A
    ASAIO J; 1998; 44(3):144-56. PubMed ID: 9617943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Present status of clinical studies of Fluosol-DA (20%) in Japan.
    Mitsuno T; Ohyanagi H
    Int Anesthesiol Clin; 1985; 23(1):169-84. PubMed ID: 3980104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery.
    Riess JG
    Artif Cells Blood Substit Immobil Biotechnol; 2005; 33(1):47-63. PubMed ID: 15768565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exchange transfusion with Fluosol 43: in vivo assessment of cerebral cytochrome c oxidase redox state.
    Sylvia AL; Proctor HJ; Goldsmith MM; Jöbsis FF
    J Trauma; 1982 Oct; 22(10):815-9. PubMed ID: 6290684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The initial response of blood leukocytes to incubation with perfluorocarbon blood substitute emulsions.
    McDonagh PF; Wilson DS
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):439-47. PubMed ID: 7493065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a perfluorochemical emulsion as a blood gas carrier.
    Mitsuno T; Ohyanagi H; Yokoyama K
    Artif Organs; 1984 Feb; 8(1):25-33. PubMed ID: 6422912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention of perfluorochemicals in rat liver and spleen.
    Lowe KC; Bentley PK
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1029-31. PubMed ID: 1391422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfluorochemical erythrocyte substitutes: disposition and effects on drug distribution and elimination.
    Ravis WR; Hoke JF; Parsons DL
    Drug Metab Rev; 1991; 23(3-4):375-411. PubMed ID: 1935577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfluorocarbon emulsion improves oxygen transport of normal and sickle cell human blood in vitro.
    Torres Filho IP; Pedro JR; Narayanan SV; Nguyen NM; Roseff SD; Spiess BD
    J Biomed Mater Res A; 2014 Jul; 102(7):2105-15. PubMed ID: 23894124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.